At the previous session the stock of Creative Medical Technology Holdings [OTCPink: CELZ] was surging 52.47% to close at $0.051. Contrary to the 30-day Average Volume of 17.27M, the Creative Medical Technology stock recorded Volume of 80.36M shares on Tuesday.
For the past 52 weeks, CELZ stock values ranged from $0.0017 to $0.1300. Despite the absence of relevant news that could cause the CELZ stock to move higher, a recent development offers an insight as to what the CELZ is up to.
- Looking For The Best Stocks To Buy For 2021? 3 Electric Vehicle Stocks To Watch
- Top 3 Cosmetics Stocks in the market
Biotechnology company Creative Medical Technology Holdings focuses on regenerative medicine and stem cell technology. The OTC-listed CELZ uses that technology in immunotherapy, urology, neurology, and orthopedics, providing solutions for unmet medical needs in these areas.
Several patented and trademarked protocols have been developed by CELZ for the treatment of multiple indications. This includes CaverStem and FemCelz brands. In addition to breaking new ground with these technologies, CELZ has also been developing ImmCelz and StemSpine.
It was announced recently that Creative Medical Technology intends to launch Virtual Physician, which will help with telehealth solutions for regenerative medicine, by the summer.
Initially, CELZ will use the platform to educate, attract and retain patients for its already commercialized procedure, along with its national provider network:
- CaverStem: A stem cell procedure that re-grows tissues and corrects erectile dysfunction in men
- FemCelz: Stem cell procedure used in the treatment of vaginal rejuvenation
The CELT Platform will expand to include additional products as they become commercially available such as StemSpine, CELZ’s regenerative stem cell therapy for treating degenerative disc disease. Also, CELZ plans to expand Virtual Physician to include additional products beyond their proprietary procedures.
What CELZ is trying to accomplish?
Creative Medical Technology (CELZ) is seeking to recruit patients for its proprietary procedures by making use of this innovative platform as telehealth can significantly accelerate the acceptance of regenerative medicine across the board. This cutting-edge industry means a lot to the CELZ, so it always puts adoption at the top of its responsibilities list.